. Effects of TIMP-1 gene knockdown on Gemcitabine-induced apoptosis in NSCLC cells. Same counts of NSCLC cells (A549 and H460) and derived TIMP-1 KD and NT clones were seeded and cultured in complete medium for two days. Equal volumes of supernatants were loaded for human TIMP-1-specific immunoblotting analysis. (B) and (C) Human NSCLC cells (A549 and H460) encoding non-target scrambled shRNA (NT) sequence or TIMP-1-specific knockdown shRNA (KD) sequence were seeded in 24-well plates (3 × 10 4 /well). At log-phase, cells were treated with variable doses of gemcitabine as indicated. All floating and adherent cells were collected at 72 hours post treatment, stained with Annexin V and PI and analyzed by flow cytometry. Representative data are shown for apoptosis and cell death of H460 (B) and A549-derived cells (C).
. Effects of TIMP-1 gene knockdown on Cisplatin-induced apoptosis in NSCLC cells. Human NSCLC cells (A549 and H460) encoding non-target scrambled shRNA (NT) sequence or TIMP-1-specific knockdown shRNA (KD) sequence were seeded on 24-well plates (3 × 10 4 /well). At log-phase, cells were treated with variable doses of Cisplatin as indicated. 
